InMed Pharmaceuticals Inc.
INM | NASDAQ
$13.21
-$4.29 (-24.53%)
At close: Nov 5, 2026, 4:00 PM ET
$13.53
+$0.32 (+2.42%)
After-hours:
Nov 5, 2026, 4:28 PM ET
Fiscal Year Period Ending | FY 2026 Jun 30, 2026 | FY 2025 Jun 30, 2025 | FY 2024 Jun 30, 2024 | FY 2023 Jun 30, 2023 | FY 2022 Jun 30, 2022 | FY 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 2.19M | 15.09M | 8.99M | 11.81M | 7.95M | 9.11M |
Short-Term Investments | 39.59K | n/a | n/a | n/a | 57.69K | 57.46K |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | -220.68M | 136.24K | 136.76K | 138.98K | 227.43K | 18.12K |
Receivables | n/a | 633.67K | 482.55K | 344.97K | 113.34K | 14.74K |
Inventory | n/a | 1.31M | 1.7M | 2.14M | 3.21M | n/a |
Other Current Assets | 446.96K | 497.47K | 712.28K | 718.62K | 57.69K | n/a |
Total Current Assets | 2.68M | 17.53M | 11.88M | 15.01M | 12.36M | 10.36M |
Property-Plant & Equipment | 221.04M | 1.35M | 1.71M | 958.37K | 1.16M | 403.91K |
Goodwill & Intangibles | n/a | 2.21M | 2.44M | 2.58M | 2.72M | 1.31M |
Total Long-Term Assets | 353.36K | 3.7M | 4.29M | 3.68M | 4.11M | 1.74M |
Total Assets | 3.03M | 21.23M | 16.17M | 18.69M | 16.46M | 12.1M |
Account Payables | 927.17K | 504.29K | 856.4K | 720.91K | 1.5M | 958.63K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 1.03M | 668.14K | 667.78K | 739.85K | 179.13K | 1.09M |
Total Current Liabilities | 1.96M | 2.51M | 2.7M | 2.65M | 4.27M | 2.74M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | 416.57K | 881.94K | 21.19K | 501.51K | 234.1K |
Total Liabilities | 1.96M | 2.92M | 3.58M | 2.67M | 4.78M | 2.97M |
Total Debt | n/a | 1.01M | 1.32M | 518.92K | 1.02M | 333.64K |
Book Value | 1.08M | 18.3M | 12.59M | 16.02M | 11.69M | 9.12M |
Book Value Per Share | 0.26 | 18.75 | 33.04 | 130.83 | 10.43K | 678.84 |
Common Stock | 94.28M | 124.28M | 113.22M | 102.83M | 91.06M | 74.93M |
Retained Earnings | -130.23M | -159.73M | -149.18M | -134.33M | -120.33M | -92.57M |
Comprehensive Income | 128.57K | 175.17K | 175.83K | 170.32K | 165.54K | 159.01K |
Shareholders Equity | 1.08M | 18.3M | 12.59M | 16.02M | 11.69M | 9.12M |
Total Investments | 39.59K | n/a | n/a | n/a | 57.69K | 57.46K |
Add to Watchlist
Select watchlists to add or remove INM